PEAK6 Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,100
Closed -$285K 4099
2024
Q1
$285K Buy
+18,100
New +$279K ﹤0.01% 2833
2022
Q1
Sell
-13,100
Closed -$447K 5720
2021
Q4
$447K Sell
13,100
-12,100
-48% -$474K ﹤0.01% 3325
2021
Q3
$1.22M Buy
+25,200
New +$1.17M ﹤0.01% 2428
2021
Q2
Sell
-104,200
Closed -$5.03M 5527
2021
Q1
$5.03M Sell
104,200
-38,400
-27% -$2M 0.01% 1057
2020
Q4
$7.68M Buy
142,600
+91,900
+181% +$4.15M 0.02% 817
2020
Q3
$1.87M Buy
50,700
+33,100
+188% +$1.23M ﹤0.01% 1723
2020
Q2
$545K Buy
17,600
+12,400
+238% +$344K ﹤0.01% 2594
2020
Q1
$144K Sell
5,200
-2,800
-35% -$83.9K ﹤0.01% 3090
2019
Q4
$234K Buy
+8,000
New +$191K ﹤0.01% 2447
2019
Q3
Sell
-15,000
Closed -$329K 4098
2019
Q2
$329K Hold
15,000
﹤0.01% 2568
2019
Q1
$307K Buy
15,000
+14,900
+14,900% +$259K ﹤0.01% 2687
2018
Q4
$1K Sell
100
-3,900
-98% -$58.1K ﹤0.01% 3888
2018
Q3
$61K Buy
+4,000
New +$55.3K ﹤0.01% 3697

Other funds holding NEO

PEAK6 Investments's NEO Position: Q1 2024 in Review

PEAK6 Investments sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 14,459 shares — an estimated $223K sold.

PEAK6 Investments first reported a position in NEO in Q3 2018 and held it in 12 quarters. The position peaked at $1.63M in Q2 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • PEAK6 Investments reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 14,459 NeoGenomics shares in Q1 2024, an estimated $223K.
  • PEAK6 Investments first reported a position in NeoGenomics in Q3 2018 and held it in 12 quarters.
  • PEAK6 Investments's NeoGenomics position peaked at $1.63M in Q2 2019.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.